AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
46 hedge funds and large institutions have $4.73M invested in Asterias Biotherapeutics Inc. Series A in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
77% less call options, than puts
Call options by funds: $9K | Put options by funds: $39K
Holders
46
Holding in Top 10
1
Calls
$9K
Puts
$39K
Top Buyers
| 1 | +$358K | |
| 2 | +$90K | |
| 3 | +$12.3K | |
| 4 |
FCMT
Founders Capital Management (Texas)
Houston,
Texas
|
+$2.29K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$1K |
Top Sellers
| 1 | -$501K | |
| 2 | -$341K | |
| 3 | -$183K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$88K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$79K |